$2.44
0.0035[0.14%]
Last update: 9:25AM Get Real Time Here
Minerva Neurosciences
(NASDAQ:NERV)Latest News for Minerva Neurosciences Stock (NASDAQ:NERV)
Minerva Neurosciences Stock (NASDAQ: NERV)
Categories: All
Friday, April 12, 2024
Tuesday, February 27, 2024
- Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat EarningsAvi Kapoor - Feb 27, 2024, 2:32PM
- Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Feb 27, 2024, 1:18PM
- Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More DataVandana Singh - Feb 27, 2024, 12:53PM
- HC Wainwright & Co. Reiterates Neutral on Minerva Neurosciences, Maintains $11 Price TargetBenzinga Newsdesk - Feb 27, 2024, 12:35PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Feb 27, 2024, 12:31PM
- Crude Oil Gains 1%; Macy's Plans To Close 150 StoresAvi Kapoor - Feb 27, 2024, 12:24PM
- Nasdaq Rises 50 Points; Lowe's Earnings Top ViewsAvi Kapoor - Feb 27, 2024, 9:42AM
- Minerva Neurosciences Shares Resume TradeBenzinga Newsdesk - Feb 27, 2024, 9:40AM
- Minerva Neurosciences Shares Halted On Circuit Breaker To The Downside, Stock Now Down -58.2%Benzinga Newsdesk - Feb 27, 2024, 9:36AM
- Minerva Neurosciences shares are trading lower after the company announced it received a Complete Response Letter from the FDA for the New Drug Application for roluperidone for the treatment of negative symptoms in patients with schizophrenia.Benzinga Newsdesk - Feb 27, 2024, 9:31AM
- Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - Feb 27, 2024, 8:25AM
- Minerva Neurosciences Receives Complete Response Letter From FDA For New Drug Application For Roluperidone For Treatment Of Negative Symptoms In Patients With Schizophrenia Due To Clinical DeficienciesBenzinga Newsdesk - Feb 27, 2024, 8:09AM
- Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - Feb 27, 2024, 7:55AM
Thursday, February 22, 2024
Thursday, February 08, 2024
Monday, February 05, 2024
Friday, October 06, 2023
- President at Minerva Neurosciences Acquires Company Stock Options Worth 87,050 SharesBenzinga Insights - Oct 6, 2023, 11:01AM
- CEO at Minerva Neurosciences Acquires Company Stock Options Worth 100,450 SharesBenzinga Insights - Oct 6, 2023, 11:01AM
- SVP at Minerva Neurosciences Acquires Company Stock Options Worth 42,850 SharesBenzinga Insights - Oct 6, 2023, 11:01AM
Friday, September 29, 2023
Wednesday, August 02, 2023
Tuesday, August 01, 2023
Tuesday, July 18, 2023
Monday, July 10, 2023
Friday, June 30, 2023
Thursday, June 29, 2023
- Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Jun 29, 2023, 1:52PM
- BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On ThursdayLisa Levin - Jun 29, 2023, 11:23AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Jun 29, 2023, 9:12AM
- Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving PremarketLisa Levin - Jun 29, 2023, 8:18AM
Wednesday, June 28, 2023
- Crude Oil Rises Sharply; Unifirst Earnings Miss ExpectationsLisa Levin - Jun 28, 2023, 2:39PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jun 28, 2023, 1:37PM
- Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jun 28, 2023, 1:04PM
- Nasdaq Moves Higher; US Crude Stocks Drop More than ProjectedLisa Levin - Jun 28, 2023, 12:22PM
- Why Minerva Neurosciences Stock Is Shooting Higher TodayNabaparna Bhattacharya - Jun 28, 2023, 10:49AM
- Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On WednesdayLisa Levin - Jun 28, 2023, 10:19AM
- Minerva Neurosciences shares are trading higher after the company announced a $20 million private placement priced at a premium to the market.Benzinga Newsdesk - Jun 28, 2023, 10:15AM
- Dow Drops 100 Points; General Mills Posts Downbeat SalesLisa Levin - Jun 28, 2023, 9:52AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jun 28, 2023, 9:12AM
- Minerva Neurosciences Announces $20M In Private Placement Priced At A Premium To MarketHappy Mohamed - Jun 28, 2023, 8:31AM